{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:21:40Z","timestamp":1790234500601,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Microsatellite instability (MSI) has emerged as a predictive biomarker for immune checkpoint inhibitor therapy. Cancer heterogeneity represents a potential obstacle for the analysis of predicitive biomarkers. MSI has been reported in pancreatic cancer, but data on the possible extent of intratumoral heterogeneity are lacking.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To study MSI heterogeneity in pancreatic cancer, a tissue microarray (TMA) comprising 597 tumors was screened by immunohistochemistry with antibodies for the mismatch repair (MMR) proteins MLH1, PMS2, MSH2, and MSH6.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In six suspicious cases, large section immunohistochemistry and microsatellite analysis (Bethesda panel) resulted in the identification of 4 (0.8%) validated MSI cases out of 480 interpretable pancreatic ductal adenocarcinomas. MSI was absent in 55 adenocarcinomas of the ampulla of Vater and 7 acinar cell carcinomas. MMR deficiency always involved MSH6 loss, in three cases with additional loss of MSH2 expression. Three cancers were MSI-high and one case with isolated MSH6 loss was MSS in PCR analysis. The analysis of 44 cancer-containing tumor blocks revealed that the loss of MMR protein expression was always homogeneous in affected tumors. Automated digital image analysis of CD8 immunostaining demonstrated markedly higher CD8\u2009+\u2009tumor infiltrating lymphocytes in tumors with (mean\u2009=\u2009685, median\u2009=\u2009626) than without (mean\u2009=\u2009227; median\u2009=\u2009124) MMR deficiency (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), suggesting a role of MSI for immune response.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data suggest that MSI occurs early in a small subset of ductal adenocarcinomas of the pancreas and that immunohistochemical MMR analysis on limited biopsy or cytology material may be sufficient to estimate MMR status of the entire cancer mass.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-020-08209-y","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T17:04:27Z","timestamp":1582823067000},"page":"3997-4006","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes"],"prefix":"10.1245","volume":"27","author":[{"given":"Christoph","family":"Fraune","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"Burandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Hube-Magg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Makrypidi-Fraune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Kluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"B\u00fcscheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"H\u00f6flmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niclas Ch.","family":"Blessin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Mandelkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob R.","family":"Izbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Wilczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Neipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Mofid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thies","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Isbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till S.","family":"Clauditz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Steurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"issue":"1","key":"8209_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7\u201330.","journal-title":"CA Cancer J Clin."},{"issue":"26","key":"8209_CR2","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer JR, Tykodi SS, Chow LQ, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012;366(26):2455\u201365.","journal-title":"N Engl J Med."},{"issue":"19","key":"8209_CR3","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1158\/1078-0432.CCR-14-2607","volume":"21","author":"A Patnaik","year":"2015","unstructured":"Patnaik A, Kang SP, Rasco D, et al. Phase I study of pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with advanced solid tumors. Clin Cancer Res. 2015;21(19):4286\u201393.","journal-title":"Clin Cancer Res."},{"issue":"26","key":"8209_CR4","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le DT, Uram JN, Wang H, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372(26):2509-2520.","journal-title":"N Engl J Med."},{"issue":"15","key":"8209_CR5","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1056\/NEJMp1709968","volume":"377","author":"S Lemery","year":"2017","unstructured":"Lemery S, Keegan P, Pazdur R. First FDA approval agnostic of cancer site\u2014when a biomarker defines the indication. N Engl J Med. 2017;377(15):1409\u201312.","journal-title":"N Engl J Med."},{"issue":"6349","key":"8209_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409\u201313.","journal-title":"Science."},{"issue":"3","key":"8209_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ygyno.2009.05.026","volume":"114","author":"FJ Backes","year":"2009","unstructured":"Backes FJ, Leon ME, Ivanov I, et al. Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer. Gynecol Oncol. 2009;114(3):486\u201390.","journal-title":"Gynecol Oncol."},{"issue":"1","key":"8209_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ygyno.2014.01.017","volume":"133","author":"AS Joehlin-Price","year":"2014","unstructured":"Joehlin-Price AS, Perrino CM, Stephens J, et al. Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables. Gynecol Oncol. 2014;133(1):43\u20137.","journal-title":"Gynecol Oncol."},{"issue":"11","key":"8209_CR9","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/nm.4191","volume":"22","author":"RJ Hause","year":"2016","unstructured":"Hause RJ, Pritchard CC, Shendure J, Salipante SJ. Classification and characterization of microsatellite instability across 18 cancer types. Nat Med. 2016;22(11):1342\u201350.","journal-title":"Nat Med."},{"issue":"23","key":"8209_CR10","doi-asserted-by":"publisher","first-page":"34546","DOI":"10.18632\/oncotarget.8945","volume":"7","author":"H Ashktorab","year":"2016","unstructured":"Ashktorab H, Ahuja S, Kannan L, et al. A meta-analysis of MSI frequency and race in colorectal cancer. Oncotarget. 2016;7(23):34546\u201357.","journal-title":"Oncotarget."},{"issue":"1","key":"8209_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4132\/KoreanJPathol.2013.47.1.28","volume":"47","author":"JY Kim","year":"2013","unstructured":"Kim JY, Shin NR, Kim A, et al. Microsatellite instability status in gastric cancer: a reappraisal of its clinical significance and relationship with mucin phenotypes. Korean J Pathol. 2013;47(1):28-35.","journal-title":"Korean J Pathol."},{"key":"8209_CR12","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202-9.","DOI":"10.1038\/nature13480"},{"issue":"1","key":"8209_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/PAI.0000000000000264","volume":"25","author":"M Mathiak","year":"2017","unstructured":"Mathiak M, Warneke VS, Behrens HM, et al. Clinicopathologic characteristics of microsatellite instable gastric carcinomas revisited: urgent need for standardization. Appl Immunohistochem Mol Morphol. 2017;25(1):12\u201324.","journal-title":"Appl Immunohistochem Mol Morphol."},{"key":"8209_CR14","doi-asserted-by":"crossref","unstructured":"Bonneville R, Krook MA, Kautto EA, et al. Landscape of microsatellite instability across 39 cancer types. JCO Precis Oncol. 2017;2017.","DOI":"10.1200\/PO.17.00073"},{"issue":"4","key":"8209_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1200\/JCO.18.00283","volume":"37","author":"A Latham","year":"2019","unstructured":"Latham A, Srinivasan P, Kemel Y, et al. Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. J Clin Oncol. 2019;37(4):286\u201395.","journal-title":"J Clin Oncol."},{"issue":"6","key":"8209_CR16","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/15384047.2015.1040960","volume":"16","author":"PP Santoiemma","year":"2015","unstructured":"Santoiemma PP, Powell DJ, Jr. Tumor infiltrating lymphocytes in ovarian cancer. Cancer Biol Ther. 2015;16(6):807\u201320.","journal-title":"Cancer Biol Ther."},{"issue":"12","key":"8209_CR17","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1080\/21645515.2015.1075106","volume":"11","author":"R Andersen","year":"2015","unstructured":"Andersen R, Donia M, Westergaard MC, Pedersen M, Hansen M, Svane IM. Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma. Hum Vaccin Immunother. 2015;11(12):2790\u20135.","journal-title":"Hum Vaccin Immunother."},{"issue":"15","key":"8209_CR18","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","volume":"29","author":"SM Mahmoud","year":"2011","unstructured":"Mahmoud SM, Paish EC, Powe DG, et al. Tumor-infiltrating CD8\u2009+\u2009lymphocytes predict clinical outcome in breast cancer. J Clin Oncol. 2011;29(15):1949\u201355.","journal-title":"J Clin Oncol."},{"issue":"12","key":"8209_CR19","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1002\/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U","volume":"91","author":"TC Smyrk","year":"2001","unstructured":"Smyrk TC, Watson P, Kaul K, Lynch HT. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer. 2001;91(12):2417\u201322.","journal-title":"Cancer."},{"issue":"9","key":"8209_CR20","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1038\/sj.bjc.6602534","volume":"92","author":"A Buckowitz","year":"2005","unstructured":"Buckowitz A, Knaebel HP, Benner A, et al. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br J Cancer. 2005;92(9):1746\u201353.","journal-title":"Br J Cancer."},{"issue":"7","key":"8209_CR21","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1097\/IGC.0000000000000482","volume":"25","author":"T Suemori","year":"2015","unstructured":"Suemori T, Susumu N, Iwata T, et al. Intratumoral CD8\u2009+\u2009lymphocyte infiltration as a prognostic factor and its relationship with cyclooxygenase 2 expression and microsatellite instability in endometrial cancer. Int J Gynecol Cancer. 2015;25(7):1165\u201372.","journal-title":"Int J Gynecol Cancer."},{"key":"8209_CR22","doi-asserted-by":"crossref","unstructured":"Eatrides JM, Coppola D, Al Diffalha S, Kim RD, Springett GM, Mahipal A. Microsatellite instability in pancreatic cancer. J Clin Oncol. 2016 2016;34(15_suppl, e15753).","DOI":"10.1200\/JCO.2016.34.15_suppl.e15753"},{"issue":"1","key":"8209_CR23","first-page":"31","volume":"54","author":"R Tomaszewska","year":"2003","unstructured":"Tomaszewska R, Okon K, Stachura J. Expression of the DNA mismatch repair proteins (hMLH1 and hMSH2) in infiltrating pancreatic cancer and its relation to some phenotypic features. Pol J Pathol. 2003;54(1):31\u20137.","journal-title":"Pol J Pathol."},{"issue":"1\u20132","key":"8209_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.bjc.6690314","volume":"80","author":"C Ghimenti","year":"1999","unstructured":"Ghimenti C, Tannergard P, Wahlberg S, et al. Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours. Br J Cancer. 1999;80(1\u20132):11\u20136.","journal-title":"Br J Cancer."},{"issue":"8","key":"8209_CR25","first-page":"2536","volume":"8","author":"B Nakata","year":"2002","unstructured":"Nakata B, Wang YQ, Yashiro M, et al. Prognostic value of microsatellite instability in resectable pancreatic cancer. Clin Cancer Res. 2002;8(8):2536\u201340.","journal-title":"Clin Cancer Res."},{"key":"8209_CR26","doi-asserted-by":"crossref","unstructured":"Joost P, Veurink N, Holck S, et al. Heterogenous mismatch-repair status in colorectal cancer. Diagn Pathol. 2014;9:126.","DOI":"10.1186\/1746-1596-9-126"},{"issue":"4","key":"8209_CR27","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/sj.bjc.6600474","volume":"87","author":"C Chapusot","year":"2002","unstructured":"Chapusot C, Martin L, Bouvier AM, et al. Microsatellite instability and intratumoural heterogeneity in 100 right-sided sporadic colon carcinomas. Br J Cancer. 2002;87(4):400\u20134.","journal-title":"Br J Cancer."},{"issue":"4","key":"8209_CR28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.2353\/jmoldx.2007.060162","volume":"9","author":"N Watson","year":"2007","unstructured":"Watson N, Grieu F, Morris M, et al. Heterogeneous staining for mismatch repair proteins during population-based prescreening for hereditary nonpolyposis colorectal cancer. J Mol Diagn. Sep 2007;9(4):472\u20138.","journal-title":"J Mol Diagn."},{"issue":"7","key":"8209_CR29","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/PAS.0000000000000663","volume":"40","author":"JC Watkins","year":"2016","unstructured":"Watkins JC, Nucci MR, Ritterhouse LL, Howitt BE, Sholl LM. Unusual mismatch repair immunohistochemical patterns in endometrial carcinoma. Am J Surg Pathol. 2016;40(7):909-16.","journal-title":"Am J Surg Pathol."},{"issue":"7","key":"8209_CR30","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1097\/PAS.0000000000000415","volume":"39","author":"RK Pai","year":"2015","unstructured":"Pai RK, Plesec TP, Abdul-Karim FW, et al. Abrupt loss of MLH1 and PMS2 expression in endometrial carcinoma: molecular and morphologic analysis of 6 cases. Am J Surg Pathol. 2015;39(7):993\u20139.","journal-title":"Am J Surg Pathol."},{"issue":"7","key":"8209_CR31","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4(7):844\u20137.","journal-title":"Nat Med."},{"key":"8209_CR32","unstructured":"R-Core-Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.2018."},{"issue":"6","key":"8209_CR33","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00345-018-2225-7","volume":"36","author":"A Hinsch","year":"2018","unstructured":"Hinsch A, Brolund M, Hube-Magg C, et al. Immunohistochemically detected IDH1(R132H) mutation is rare and mostly heterogeneous in prostate cancer. World J Urol. 2018;36(6):877\u201382.","journal-title":"World J Urol."},{"issue":"1 Pt 1","key":"8209_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1158\/1078-0432.CCR-0597-3","volume":"10","author":"R Simon","year":"2004","unstructured":"Simon R, Panussis S, Maurer R, et al. KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations. Clin Cancer Res. 2004;10(1 Pt 1):178\u2013183.","journal-title":"Clin Cancer Res."},{"issue":"5","key":"8209_CR35","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1158\/1541-7786.MCR-17-0735","volume":"16","author":"ME Salem","year":"2018","unstructured":"Salem ME, Puccini A, Grothey A, et al. Landscape of tumor mutation load, mismatch repair deficiency, and pd-l1 expression in a large patient cohort of gastrointestinal cancers. Mol Cancer Res. 2018;16(5):805\u201312.","journal-title":"Mol Cancer Res."},{"issue":"6","key":"8209_CR36","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1158\/1078-0432.CCR-17-3099","volume":"24","author":"ZI Hu","year":"2018","unstructured":"Hu ZI, Shia J, Stadler ZK, et al. Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations. Clin Cancer Res. 2018;24(6):1326\u201336.","journal-title":"Clin Cancer Res."},{"issue":"10","key":"8209_CR37","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/modpathol.2015.89","volume":"28","author":"M Riazy","year":"2015","unstructured":"Riazy M, Kalloger SE, Sheffield BS, et al. Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma. Mod Pathol. 2015;28(10):1383-9.","journal-title":"Mod Pathol."},{"issue":"4","key":"8209_CR38","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1053\/j.gastro.2017.11.009","volume":"154","author":"RM Lupinacci","year":"2018","unstructured":"Lupinacci RM, Goloudina A, Buhard O, et al. Prevalence of microsatellite instability in intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology. 2018;154(4):1061\u20135.","journal-title":"Gastroenterology."},{"issue":"5","key":"8209_CR39","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0002-9440(10)65035-3","volume":"156","author":"RE Wilentz","year":"2000","unstructured":"Wilentz RE, Goggins M, Redston M, et al. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol. 2000;156(5):1641\u201351.","journal-title":"Am J Pathol."},{"key":"8209_CR40","doi-asserted-by":"crossref","unstructured":"Fraune C, Simon R, Hoflmayer D, et al. High homogeneity of mismatch repair deficiency in advanced prostate cancer. Virchows Arch. 2019.","DOI":"10.1007\/s00428-019-02701-x"},{"issue":"8","key":"8209_CR41","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1097\/MPA.0000000000000190","volume":"43","author":"W Liu","year":"2014","unstructured":"Liu W, Shia J, Gonen M, Lowery MA, O\u2019Reilly EM, Klimstra DS. DNA mismatch repair abnormalities in acinar cell carcinoma of the pancreas: frequency and clinical significance. Pancreas. 2014;43(8):1264\u201370.","journal-title":"Pancreas."},{"issue":"5","key":"8209_CR42","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1309\/AJCPGDDE8PLLDRCC","volume":"133","author":"NP Agaram","year":"2010","unstructured":"Agaram NP, Shia J, Tang LH, Klimstra DS. DNA mismatch repair deficiency in ampullary carcinoma: a morphologic and immunohistochemical study of 54 cases. Am J Clin Pathol. 2010;133(5):772\u201380.","journal-title":"Am J Clin Pathol."},{"issue":"24","key":"8209_CR43","doi-asserted-by":"publisher","first-page":"13629","DOI":"10.1073\/pnas.93.24.13629","volume":"93","author":"S Acharya","year":"1996","unstructured":"Acharya S, Wilson T, Gradia S, et al. hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc Natl Acad Sci U S A. 1996;93(24):13629\u201334.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"8209_CR44","doi-asserted-by":"publisher","first-page":"e1006739","DOI":"10.1371\/journal.pgen.1006739","volume":"13","author":"SV Nielsen","year":"2017","unstructured":"Nielsen SV, Stein A, Dinitzen AB, et al. Predicting the impact of Lynch syndrome-causing missense mutations from structural calculations. PLoS Genet. 2017;13(4):e1006739.","journal-title":"PLoS Genet."},{"issue":"15","key":"8209_CR45","doi-asserted-by":"publisher","first-page":"8568","DOI":"10.1073\/pnas.95.15.8568","volume":"95","author":"G Marra","year":"1998","unstructured":"Marra G, Iaccarino I, Lettieri T, Roscilli G, Delmastro P, Jiricny J. Mismatch repair deficiency associated with overexpression of the MSH3 gene. Proc Natl Acad Sci U S A. 1998;95(15):8568\u201373.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"24","key":"8209_CR46","doi-asserted-by":"publisher","first-page":"18424","DOI":"10.1074\/jbc.M001140200","volume":"275","author":"DK Chang","year":"2000","unstructured":"Chang DK, Ricciardiello L, Goel A, Chang CL, Boland CR. Steady-state regulation of the human DNA mismatch repair system. J Biol Chem. 2000;275(24):18424\u201331.","journal-title":"J Biol Chem."},{"issue":"1","key":"8209_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pathol.2018.09.057","volume":"51","author":"J Cho","year":"2019","unstructured":"Cho J, Kang SY, Kim KM. MMR protein immunohistochemistry and microsatellite instability in gastric cancers. Pathology. 2019;51(1):110\u20133.","journal-title":"Pathology."},{"issue":"1","key":"8209_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4103\/0973-1482.110382","volume":"9","author":"HJ Lee","year":"2013","unstructured":"Lee HJ, Jang YJ, Lee EJ, et al. The significance of mismatch repair genes in gastric cancer. J Cancer Res Ther. 2013;9(1):80\u20133.","journal-title":"J Cancer Res Ther. Jan-Mar"},{"issue":"1","key":"8209_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10689-013-9671-6","volume":"13","author":"AM Metcalf","year":"2014","unstructured":"Metcalf AM, Spurdle AB. Endometrial tumour BRAF mutations and MLH1 promoter methylation as predictors of germline mismatch repair gene mutation status: a literature review. Fam Cancer.2014;13(1):1\u201312.","journal-title":"Fam Cancer."},{"issue":"11","key":"8209_CR50","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1097\/PAS.0000000000000321","volume":"38","author":"AM Mills","year":"2014","unstructured":"Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Am J Surg Pathol. 2014;38(11):1501\u20139.","journal-title":"Am J Surg Pathol."},{"issue":"15","key":"8209_CR51","first-page":"3455","volume":"58","author":"JM Cunningham","year":"1998","unstructured":"Cunningham JM, Christensen ER, Tester DJ, et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. Aug 1 1998;58(15):3455\u201360.","journal-title":"Cancer Res."},{"issue":"2","key":"8209_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10689-017-0019-5","volume":"17","author":"TP Slavin","year":"2018","unstructured":"Slavin TP, Neuhausen SL, Nehoray B, et al. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes. Fam Cancer. 2018;17(2):235\u201345.","journal-title":"Fam Cancer."},{"issue":"2","key":"8209_CR53","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1158\/1940-6207.CAPR-11-0288","volume":"5","author":"AN Bartley","year":"2012","unstructured":"Bartley AN, Luthra R, Saraiya DS, Urbauer DL, Broaddus RR. Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing. Cancer Prev Res (Phila). 2012;5(2):320\u20137.","journal-title":"Cancer Prev Res (Phila)."},{"issue":"3","key":"8209_CR54","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jmoldx.2010.12.004","volume":"13","author":"MS Cicek","year":"2011","unstructured":"Cicek MS, Lindor NM, Gallinger S, et al. Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. J Mol Diagn. May 2011;13(3):271\u201381.","journal-title":"J Mol Diagn."},{"issue":"1","key":"8209_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ijc.21313","volume":"118","author":"C Engel","year":"2006","unstructured":"Engel C, Forberg J, Holinski-Feder E, et al. Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer. Int J Cancer. 2006;118(1):115\u201322.","journal-title":"Int J Cancer."},{"issue":"1","key":"8209_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1086\/337944","volume":"70","author":"MJ Berends","year":"2002","unstructured":"Berends MJ, Wu Y, Sijmons RH, et al. Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am J Hum Genet. Jan 2002;70(1):26-37.","journal-title":"Am J Hum Genet."},{"issue":"4","key":"8209_CR57","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/genetics\/148.4.1637","volume":"148","author":"A Umar","year":"1998","unstructured":"Umar A, Risinger JI, Glaab WE, Tindall KR, Barrett JC, Kunkel TA. Functional overlap in mismatch repair by human MSH3 and MSH6. Genetics. 1998;148(4):1637\u201346.","journal-title":"Genetics."},{"issue":"22","key":"8209_CR58","first-page":"5248","volume":"58","author":"CR Boland","year":"1998","unstructured":"Boland CR, Thibodeau SN, Hamilton SR, et al. A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58(22):5248\u201357.","journal-title":"Cancer Res."},{"issue":"7412","key":"8209_CR59","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature11273","volume":"488","author":"B Schuster-Bockler","year":"2012","unstructured":"Schuster-Bockler B, Lehner B. Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature. 2012;488(7412):504\u20137.","journal-title":"Nature."},{"issue":"7550","key":"8209_CR60","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nature14173","volume":"521","author":"F Supek","year":"2015","unstructured":"Supek F, Lehner B. Differential DNA mismatch repair underlies mutation rate variation across the human genome. Nature. 2015;521(7550):81\u20134.","journal-title":"Nature."},{"key":"8209_CR61","doi-asserted-by":"crossref","unstructured":"De Rosa S, Sahnane N, Tibiletti MG, et al. EBV(+) and MSI Gastric Cancers Harbor High PD-L1\/PD-1 Expression and High CD8(+) Intratumoral Lymphocytes. Cancers (Basel). 2018;10(4).","DOI":"10.3390\/cancers10040102"},{"key":"8209_CR62","unstructured":"IASLC. IASLC Atlas of ALK and ROS1 testing in Lung Cancer Editorial Rx Press; Second Edition, 2016."},{"key":"8209_CR63","unstructured":"NCCN Flash Update: Pancreatic Adenocarcinoma. https:\/\/www.nccn.org\/about\/news\/ebulletin\/ebulletindetail.aspx?ebulletinid=1193. Accessed 12 Dec 2019."},{"issue":"3","key":"8209_CR64","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/cam4.1372","volume":"7","author":"A Vanderwalde","year":"2018","unstructured":"Vanderwalde A, Spetzler D, Xiao N, Gatalica Z, Marshall J. Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients. Cancer Med. 2018;7(3):746\u201356.","journal-title":"Cancer Med."},{"issue":"9","key":"8209_CR65","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1373\/clinchem.2014.223677","volume":"60","author":"SJ Salipante","year":"2014","unstructured":"Salipante SJ, Scroggins SM, Hampel HL, Turner EH, Pritchard CC. Microsatellite instability detection by next generation sequencing. Clin Chem. 2014;60(9):1192\u20139.","journal-title":"Clin Chem."},{"issue":"10","key":"8209_CR66","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/s41379-019-0291-z","volume":"32","author":"Y Masugi","year":"2019","unstructured":"Masugi Y, Abe T, Ueno A, et al. Characterization of spatial distribution of tumor-infiltrating CD8(+) T cells refines their prognostic utility for pancreatic cancer survival. Mod Pathol. 2019;32(10):1495\u2013507.","journal-title":"Mod Pathol."},{"key":"8209_CR67","doi-asserted-by":"crossref","unstructured":"Hou YC, Chao YJ, Hsieh MH, Tung HL, Wang HC, Shan YS. Low CD8(+) t cell infiltration and high pd-l1 expression are associated with level of cd44(+)\/cd133(+) cancer stem cells and predict an unfavorable prognosis in pancreatic cancer. Cancers (Basel). 2019;11(4).","DOI":"10.3390\/cancers11040541"},{"key":"8209_CR68","doi-asserted-by":"crossref","unstructured":"Miksch RC, Schoenberg MB, Weniger M, et al. Prognostic Impact of Tumor-Infiltrating Lymphocytes and Neutrophils on Survival of Patients with Upfront Resection of Pancreatic Cancer. Cancers (Basel). 2019;11(1).","DOI":"10.3390\/cancers11010039"},{"issue":"16","key":"8209_CR69","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","volume":"18","author":"C Feig","year":"2012","unstructured":"Feig C, Gopinathan A, Neesse A, Chan DS, Cook N, Tuveson DA. The pancreas cancer microenvironment. Clin Cancer Res. 2012;18(16):4266\u201376.","journal-title":"Clin Cancer Res."},{"key":"8209_CR70","doi-asserted-by":"crossref","unstructured":"Tahkola K, Mecklin JP, Wirta EV, et al. High immune cell score predicts improved survival in pancreatic cancer. Virchows Arch. 2018;472(4):653\u201365.","DOI":"10.1007\/s00428-018-2297-1"}],"updated-by":[{"DOI":"10.1245\/s10434-022-11798-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000}}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08209-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-08209-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08209-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T19:41:01Z","timestamp":1650570061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-08209-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":70,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["8209"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08209-y","relation":{"correction":[{"id-type":"doi","id":"10.1245\/s10434-022-11798-5","asserted-by":"object"}]},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,27]]},"assertion":[{"value":"29 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1245\/s10434-022-11798-5","URL":"https:\/\/doi.org\/10.1245\/s10434-022-11798-5","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interst.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}